Group 1 - The article discusses a class action lawsuit against Charming Medical Limited (MCTA) for securities fraud, with a deadline for shareholders to file a lead plaintiff motion by February 17, 2026 [1] - The lawsuit claims that during the class period from October 10, 2025, to November 12, 2025, the company made materially false and misleading statements regarding its business and operations [1] - The SEC halted trading of Charming securities on November 11, 2025, due to potential manipulation through social media recommendations aimed at artificially inflating the stock price [1] Group 2 - Allegations in the lawsuit include that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign, and that the company failed to disclose material adverse facts [1] - The complaint asserts that the company's public statements omitted any mention of false rumors and artificial trading activity that influenced the stock price [1] - Shareholders who acquired Charming securities during the class period are encouraged to participate in the lawsuit to recover losses under federal securities laws [1]
Deadline Alert: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit